Table 4.

Summarized results of the simulations. Costs, strokes, and fatal strokes classified on the basis of the CHA₂DS₂-VASc score as well as the investigated group (N=30,000 patients per group per score).

	Study arm with device (75% ECGa confirmation)				Study arm with device (100% ECG confirmation)
CHA2DS2-VASc scoreb	Average costs per patient (in €c, whole simulation duration)	Total number of strokesd	Number of nonfatal strokes	Number of fatal strokes		Average costs per patient (in €, whole simulation duration)	Total number of strokesd	Number of nonfatal strokes	Number of fatal strokes
1	1314	556	361	195		1290	528	331	197
2	2847	2406	1585	821		2876	2364	1550	814
3	3887	3395	2180	1215		3876	3339	2180	1159
4	5380	4994	3204	1790		5421	4894	3154	1740
5	7483	7444	4751	2693		7543	7263	4700	2563
6	9427	9755	6084	3671		9508	9549	6107	3442
7	10,646	11,082	6901	4181		10,627	10,703	6771	3932
8	10,846	10,374	6295	4079		10,937	10,122	6301	3821
9	12,146	11,449	6756	4693		12,463	11,210	6897	4313
mean	7108	6828	4235	2593		7171	6664	4221	2442

^aECG: electrocardiography.

^bCHA₂DS₂-VASc: Congestive heart failure, Hypertension, Age≥75 years, Diabetes mellitus, Stroke, Vascular disease, Age 65-74 years, Sex category (female).

^c€1=US $1.12.

^dTotal number of strokes includes nonfatal and fatal strokes.